EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular CarcinomaShu-Bin Gao, Guang‐Hui Jin, Qi‐Fan Zheng et al.|Molecular Cancer Research|2014Cited by 69
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitorTengrui Zhang, Lixiang Xue|EBioMedicine|2022Cited by 42
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.Shu-Bin Gao, Lixiang Xue, Shi Shu et al.|PubMed|2017Cited by 18
Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatmentLixiang Xue|EBioMedicine|2025Cited by 1
Supplementary Methods, Figures 1 - 3, Tables 1 - 3 from EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular CarcinomaShu-Bin Gao, Guanghui Jin, Qi‐Fan Zheng et al.|Unknown|2023Cited by 0